ASX - By Stock
|
OAK |
Re:
Ann: ASX Waiver
|
|
Juronomo
|
11 |
3.6K |
1 |
22/12/16 |
22/12/16 |
ASX - By Stock
|
11
|
3.6K
|
1
|
|
ASX - By Stock
|
OAK |
Re:
Ann: ASX Waiver
|
|
Juronomo
|
11 |
3.6K |
0 |
22/12/16 |
22/12/16 |
ASX - By Stock
|
11
|
3.6K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Mente Autism Shipment
|
|
Juronomo
|
51 |
15K |
3 |
22/12/16 |
22/12/16 |
ASX - By Stock
|
51
|
15K
|
3
|
|
ASX - By Stock
|
OAK |
Re:
Rebound?
|
|
Juronomo
|
55 |
13K |
2 |
21/12/16 |
21/12/16 |
ASX - By Stock
|
55
|
13K
|
2
|
|
Charts
|
NTI |
Re:
NTI Chart
|
|
Juronomo
|
377 |
120K |
2 |
21/12/16 |
21/12/16 |
Charts
|
377
|
120K
|
2
|
|
ASX - By Stock
|
OAK |
Re:
Rebound?
|
|
Juronomo
|
55 |
13K |
1 |
21/12/16 |
21/12/16 |
ASX - By Stock
|
55
|
13K
|
1
|
|
IPOs
|
|
Re:
Sensera Systems
|
|
Juronomo
|
80 |
32K |
0 |
20/12/16 |
20/12/16 |
IPOs
|
80
|
32K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Scientific Advisory Board
|
|
Juronomo
|
24 |
7.5K |
2 |
20/12/16 |
20/12/16 |
ASX - By Stock
|
24
|
7.5K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Scientific Advisory Board
|
|
Juronomo
|
24 |
7.5K |
4 |
20/12/16 |
20/12/16 |
ASX - By Stock
|
24
|
7.5K
|
4
|
|
ASX - By Stock
|
IRX |
Re:
LSH general discussion
|
|
Juronomo
|
421 |
128K |
1 |
20/12/16 |
20/12/16 |
ASX - By Stock
|
421
|
128K
|
1
|
|
ASX - By Stock
|
OAK |
Re:
Ann: Prospectus
|
|
Juronomo
|
137 |
37K |
0 |
20/12/16 |
20/12/16 |
ASX - By Stock
|
137
|
37K
|
0
|
|
ASX - By Stock
|
IRX |
Re:
LSH general discussion
|
|
Juronomo
|
421 |
128K |
0 |
20/12/16 |
20/12/16 |
ASX - By Stock
|
421
|
128K
|
0
|
|
ASX - By Stock
|
OAK |
Re:
Ann: Prospectus
|
|
Juronomo
|
137 |
37K |
0 |
19/12/16 |
19/12/16 |
ASX - By Stock
|
137
|
37K
|
0
|
|
ASX - By Stock
|
OAK |
Re:
Ann: Prospectus
|
|
Juronomo
|
137 |
37K |
3 |
17/12/16 |
17/12/16 |
ASX - By Stock
|
137
|
37K
|
3
|
|
ASX - By Stock
|
OAK |
Re:
Ann: Prospectus
|
|
Juronomo
|
137 |
37K |
2 |
17/12/16 |
17/12/16 |
ASX - By Stock
|
137
|
37K
|
2
|
|
ASX - By Stock
|
OAK |
Re:
Ann: Prospectus
|
|
Juronomo
|
137 |
37K |
1 |
17/12/16 |
17/12/16 |
ASX - By Stock
|
137
|
37K
|
1
|
|
Charts
|
NTI |
Re:
CEO follow up points
|
|
Juronomo
|
2 |
1.4K |
6 |
17/12/16 |
17/12/16 |
Charts
|
2
|
1.4K
|
6
|
|
ASX - By Stock
|
CAT |
Re:
Ann: Catapult targets 21-30% revenue growth in FY17
|
|
Juronomo
|
52 |
24K |
4 |
16/12/16 |
16/12/16 |
ASX - By Stock
|
52
|
24K
|
4
|
|
ASX - By Stock
|
OAK |
Re:
Ann: Company Update - Complex Semi iCharger
|
|
Juronomo
|
70 |
18K |
2 |
16/12/16 |
16/12/16 |
ASX - By Stock
|
70
|
18K
|
2
|
|
ASX - By Stock
|
OAK |
Re:
Ann: Company Update - Complex Semi iCharger
|
|
Juronomo
|
70 |
18K |
14 |
15/12/16 |
15/12/16 |
ASX - By Stock
|
70
|
18K
|
14
|
|
ASX - By Stock
|
HXG |
Re:
Corporate news awaiting
|
|
Juronomo
|
26 |
9.4K |
0 |
14/12/16 |
14/12/16 |
ASX - By Stock
|
26
|
9.4K
|
0
|
|
ASX - By Stock
|
HXG |
Re:
Corporate news awaiting
|
|
Juronomo
|
26 |
9.4K |
3 |
14/12/16 |
14/12/16 |
ASX - By Stock
|
26
|
9.4K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
An attempt at a valuation....
|
|
Juronomo
|
39 |
14K |
0 |
12/12/16 |
12/12/16 |
ASX - By Stock
|
39
|
14K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
An attempt at a valuation....
|
|
Juronomo
|
39 |
14K |
3 |
09/12/16 |
09/12/16 |
ASX - By Stock
|
39
|
14K
|
3
|
|
Charts
|
RAP |
Re:
week of dec 5 us trials will start !
|
|
Juronomo
|
10 |
6.5K |
5 |
09/12/16 |
09/12/16 |
Charts
|
10
|
6.5K
|
5
|
|
ASX - By Stock
|
NTI |
Re:
AMA report on autism
|
|
Juronomo
|
6 |
2.8K |
7 |
08/12/16 |
08/12/16 |
ASX - By Stock
|
6
|
2.8K
|
7
|
|
ASX - By Stock
|
IRX |
Re:
LSH general discussion
|
|
Juronomo
|
421 |
128K |
1 |
08/12/16 |
08/12/16 |
ASX - By Stock
|
421
|
128K
|
1
|
|
ASX - By Stock
|
IRX |
Re:
LSH general discussion
|
|
Juronomo
|
421 |
128K |
0 |
08/12/16 |
08/12/16 |
ASX - By Stock
|
421
|
128K
|
0
|
|
Charts
|
NTI |
Re:
NTI Chart
|
|
Juronomo
|
377 |
120K |
3 |
07/12/16 |
07/12/16 |
Charts
|
377
|
120K
|
3
|
|
ASX - By Stock
|
CAT |
Re:
Ann: Catapult targets 21-30% revenue growth in FY17
|
|
Juronomo
|
52 |
24K |
1 |
07/12/16 |
07/12/16 |
ASX - By Stock
|
52
|
24K
|
1
|
|
ASX - By Stock
|
CAT |
Re:
Ann: Catapult targets 21-30% revenue growth in FY17
|
|
Juronomo
|
52 |
24K |
0 |
07/12/16 |
07/12/16 |
ASX - By Stock
|
52
|
24K
|
0
|
|
ASX - By Stock
|
CAT |
Re:
Ann: Catapult targets 21-30% revenue growth in FY17
|
|
Juronomo
|
52 |
24K |
0 |
06/12/16 |
06/12/16 |
ASX - By Stock
|
52
|
24K
|
0
|
|
ASX - By Stock
|
CAT |
Re:
Ann: Catapult targets 21-30% revenue growth in FY17
|
|
Juronomo
|
52 |
24K |
1 |
06/12/16 |
06/12/16 |
ASX - By Stock
|
52
|
24K
|
1
|
|
ASX - By Stock
|
CAT |
Re:
Ann: Catapult targets 21-30% revenue growth in FY17
|
|
Juronomo
|
52 |
24K |
0 |
04/12/16 |
04/12/16 |
ASX - By Stock
|
52
|
24K
|
0
|
|
ASX - By Stock
|
CAT |
Re:
Ann: Catapult targets 21-30% revenue growth in FY17
|
|
Juronomo
|
52 |
24K |
1 |
04/12/16 |
04/12/16 |
ASX - By Stock
|
52
|
24K
|
1
|
|
ASX - By Stock
|
CL1 |
Re:
Motley Fool class dirt cheap?
|
|
Juronomo
|
10 |
12K |
0 |
03/12/16 |
03/12/16 |
ASX - By Stock
|
10
|
12K
|
0
|
|
ASX - By Stock
|
CAT |
Re:
Ann: Catapult targets 21-30% revenue growth in FY17
|
|
Juronomo
|
52 |
24K |
0 |
02/12/16 |
02/12/16 |
ASX - By Stock
|
52
|
24K
|
0
|
|
ASX - By Stock
|
CAT |
Re:
Ann: Catapult targets 21-30% revenue growth in FY17
|
|
Juronomo
|
52 |
24K |
1 |
02/12/16 |
02/12/16 |
ASX - By Stock
|
52
|
24K
|
1
|
|
ASX - By Stock
|
CAT |
Re:
Ann: Catapult targets 21-30% revenue growth in FY17
|
|
Juronomo
|
52 |
24K |
1 |
02/12/16 |
02/12/16 |
ASX - By Stock
|
52
|
24K
|
1
|
|
ASX - By Stock
|
CAT |
Re:
Ann: Catapult targets 21-30% revenue growth in FY17
|
|
Juronomo
|
52 |
24K |
2 |
02/12/16 |
02/12/16 |
ASX - By Stock
|
52
|
24K
|
2
|
|
ASX - By Stock
|
CAT |
Re:
Ann: Catapult targets 21-30% revenue growth in FY17
|
|
Juronomo
|
52 |
24K |
0 |
01/12/16 |
01/12/16 |
ASX - By Stock
|
52
|
24K
|
0
|
|
Charts
|
NTI |
Re:
NTI Chart
|
|
Juronomo
|
377 |
120K |
3 |
30/11/16 |
30/11/16 |
Charts
|
377
|
120K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: AGM Results
|
|
Juronomo
|
19 |
7.0K |
3 |
29/11/16 |
29/11/16 |
ASX - By Stock
|
19
|
7.0K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Investor Presentation
|
|
Juronomo
|
120 |
33K |
4 |
29/11/16 |
29/11/16 |
ASX - By Stock
|
120
|
33K
|
4
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Investor Presentation
|
|
Juronomo
|
120 |
33K |
4 |
29/11/16 |
29/11/16 |
ASX - By Stock
|
120
|
33K
|
4
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Investor Presentation
|
|
Juronomo
|
120 |
33K |
0 |
29/11/16 |
29/11/16 |
ASX - By Stock
|
120
|
33K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Investor Presentation
|
|
Juronomo
|
120 |
33K |
1 |
29/11/16 |
29/11/16 |
ASX - By Stock
|
120
|
33K
|
1
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Investor Presentation
|
|
Juronomo
|
120 |
33K |
1 |
29/11/16 |
29/11/16 |
ASX - By Stock
|
120
|
33K
|
1
|
|
ASX - By Stock
|
NTI |
Re:
NTI Rundown + Clinical trial update
|
|
Juronomo
|
462 |
95K |
4 |
29/11/16 |
29/11/16 |
ASX - By Stock
|
462
|
95K
|
4
|
|
ASX - By Stock
|
OAK |
Re:
Copy of Letter (email) to Athan and the Board
|
|
Juronomo
|
180 |
53K |
4 |
29/11/16 |
29/11/16 |
ASX - By Stock
|
180
|
53K
|
4
|
|